Stay updated on ADXS31-142 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the ADXS31-142 in mCRPC Clinical Trial page.

Latest updates to the ADXS31-142 in mCRPC Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. This appears to be a metadata version update and does not change study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe site revision tag changed from v3.4.2 to v3.4.3. There are no changes to the study content or critical page information.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice (Revision: v3.4.1) as administrative site updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedMinor UI and editorial updates were made to the study page, including a glossary toggle label, capitalization tweaks in update metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data), and a new revision tag (v3.4.0) replacing the old v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check98 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (California, Colorado, Maryland, New Jersey, Pennsylvania, Rhode Island) and updated the version to v3.3.3; removed the standalone state location entries and the HHS Vulnerability Disclosure link.SummaryDifference0.8%

Stay in the know with updates to ADXS31-142 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS31-142 in mCRPC Clinical Trial page.